H|T: The Healthtech Times – Ontario budget allocates funding to healthtech procurement
Plus: Neuralink is now accepting Canadian patients.
Stay updated with breaking news from Immune Profiler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Plus: Neuralink is now accepting Canadian patients.
Georgiamune and Verily forms a strategic partnership to advance novel therapeutics for patients with cancer.
Nomination of novel drug target based on insights generated through application of Verily’s Immune Profiler platform and Sosei Heptares’ GPCR-focused structure-based drug design expertise ...
/PRNewswire/ -- Verily, an Alphabet precision health technology company, and Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company...
This is an important day for Verily, as we announce our refined strategy, prioritized portfolio and simplified operating model. This is work...